Slide background

Slide background
Slide background

Contact Us

Research Sequencing

The New York Genome Center (NYGC) has embarked on a new strategic direction to drive genomic discovery in neurological diseases and cancer.


Our mission is to apply our strengths in whole genome sequencing, RNA sequencing, state-of-the-art analytics, and the development of genetic tools to further genomic research that leads to scientific advances and new insights and therapies for patients with neurodegenerative diseases, neuropsychiatric diseases, and cancer.


Our research is focused on three disease areas:


We will support these three disease-research areas with our ongoing commitment to technology innovation, particularly in single cell and spatial transcriptomics. This will include expanding our computational efforts dedicated to the analyses of these transcriptomic data, to population-level statistical analyses, and to the integration of these datasets.


We will also continue to support large-scale population genomic projects outside of our focused disease areas.


We look forward to working closely with the extraordinary scientific and clinical leadership among our faculty, staff scientists, Institutional Founding Members (IFMs) and other research partners to build new collaborations, and to jointly attract new public and private funding.


Please feel free to contact our project management team with any questions about projects, collaborations, grants, or other ways to become engaged with the NYGC.

Research Sequencing Terms and Conditions